TSXV - Delayed Quote CAD

Conavi Medical Corp. (CNVI.V)

0.3900

-0.0100

(-2.50%)

At close: April 29 at 3:49:32 PM EDT

CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.

TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. (“CPOINT”) announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP (“Juno”) acquired 1,875,000 common shares (the “Common Shares”) in the capital of Conavi Medical Corp. (the “Company”) (625,000 of which are held by CPOINT and 1,250,000 of which are held by Juno), in connection with a public offering of the Company by way of a short form prospectus dated April 15, 2025. CPOINT and its affiliate Juno purchase

GlobeNewswire 4 days ago

CNVIF
0.00%
Conavi Medical to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

Toronto, Ontario--(Newsfile Corp. - April 25, 2025) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO of Conavi Medical, will present and participate in one-on-one meetings at the 2025 Bloom Burton & Co. Healthcare Investor Conference being held in Toront

Newsfile 4 days ago

CNVIF
0.00%
Conavi Medical Corp. Announces Closing of $20M Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce that it has closed its previously announced, upsized equity offering for aggregate gross pro

GlobeNewswire 6 days ago

CNVIF
0.00%
Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES A&R PROSPECTUS AND FINAL PROSPECTUS ACCESSIBLE ON SEDAR+ TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce the pricing and terms of its previo

GlobeNewswire 14 days ago

CNVIF
0.00%
Conavi Medical Announces Results From Its Annual General Meeting of Shareholders and Adoption of Amendments to Omnibus Equity Incentive Plan

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, announced today the results of its annual general meeting of shareholders held virtually on March 31, 2025 (the “Meeting”), as well as the adoption of amendments to the Company’s Stock Option Pla

GlobeNewswire 28 days ago

CNVIF
0.00%
Conavi Medical Corp. Announces Upsize to its Previously Announced Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 21, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to provide an update in respect of its previously announced public offering (the “Offering”). The Compan

GlobeNewswire last month

CNVIF
0.00%
Conavi Medical Announces Uplisting to OTCQB Venture Market

- Expected to enhance visibility and access to U.S. investors - Trading to commence on March 6, 2025 TORONTO, March 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that its common shares have been approved for uplisting from the OTC Pink Open

GlobeNewswire last month

CNVIF
0.00%
Conavi Medical Highly Encouraged by New U.S. Intracoronary Guidelines

– IVUS and OCT cited as playing essential and complementary roles, validating Novasight’s unique hybrid imaging capability – Guidelines constitute strong recommendations based on the highest level of evidence – Clinical data show intracoronary imaging leads to lower risk of target vessel failure (including cardiac death) in coronary procedures – Company anticipates similar changes to other guidelines covering coronary procedures TORONTO, March 04, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (T

GlobeNewswire last month

CNVIF
0.00%
Conavi Medical Reports Fiscal Q1 2025 Interim Financial Results and Operational Highlights

– Completed first quarter as a public company and raised $10.6 mil CAD concurrent with listing – Next-generation Novasight design freeze completed on schedule, usability testing and system validation expected to complete next quarter – U.S. FDA submission on track for Q3 calendar 2025 TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imagin

GlobeNewswire last month

CNVIF
0.00%
Conavi Medical Retains BND Projects Inc. for Corporate Development Services

TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Corporation”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedure, is pleased to announce that it has entered into a Corporate Development and Strategic services agreement with BND Projects Inc. (“BND”). BND will advise on corporate developments and strategic investment matters, in

GlobeNewswire 2 months ago

CNVIF
0.00%
Conavi Medical Corp. Announces Proposed Public Offering of Units

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES TORONTO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedure, announced today that it has filed a preliminary short form prospectus with the securities regulato

GlobeNewswire 2 months ago

CNVIF
0.00%
Conavi Medical Provides Shareholder Update and 2025 Outlook

- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight system as new imaging standard in interventional cardiology- Multiple non-dilutive opportunities being pursued to fund growth TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) -- To our Shareholders, As we enter 2025, I’m encouraged by our recent progress and the favorable strategic landscape. Having completed o

GlobeNewswire 3 months ago

CNVIF
0.00%
Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review

TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce the publication of a detailed review of its collaboration with U.S.-based Minnetronix, a world leader in high-precision medical device manufacturing. Published in the industry

GlobeNewswire 3 months ago

CNVIF
0.00%
Conavi Medical Announces Grant of Stock Options

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”) announced that its board of directors (the “Board”) has approved grants of stock options (the “Stock Options”) pursuant to the terms of the Omnibus Equity Incentive Plan effective January 2nd, 2025. A total of 1,073,685 Stock Options have been awarded to directors, officers, employees and consultants of the Company. The Stock Options are exercisable at a price of $0.70 CAD per share (

GlobeNewswire 3 months ago

CNVIF
0.00%
Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights

– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million payment, enabling Company to fully repay debt to that partner – U.S. FDA submission of Novasight 3.0 system on track for calendar 2025 TORONTO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on design

GlobeNewswire 4 months ago

CNVIF
0.00%
Conavi Medical to Participate in the MedInvest MedTech, AI & Digital Health Conference

– Marks first time as a public company that Conavi is presenting at an investor event – – Live webcast presentation on Wednesday, December 11ᵗʰ at 3:35 p.m. ET – TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”), a commercial stage company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that its Chief Executive Officer, Thomas Looby,

GlobeNewswire 4 months ago

CNVIF
0.00%
China's NMPA Approves EOM’s Coronary Imaging System Based on Conavi Medical’s IP

– Approval triggers fourth and final US$5.9 million milestone payment to Conavi Medical, which it will use to extinguish the promissory note owed by it to EOM – – Conavi Medical eligible to receive future tiered royalty payments, ranging from 5.0%-10.0%, on net EOM coronary imaging system sales in China – TORONTO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”), a commercial stage company focused on designing, manufacturing, and marketing i

GlobeNewswire 4 months ago

CNVIF
0.00%
Conavi Medical Inc. (CNVI) Opens the Market

Toronto, Ontario--(Newsfile Corp. - December 5, 2024) - Thomas Looby, Chief Executive Officer, Conavi Medical Inc. (TSXV: CNVI) ("Conavi Medical" or the "Company"), and his team, joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market to celebrate the Company's new listing on the TSX Venture Exchange.Cannot view this video? Visit:https://www.youtube.com/watch?v=MRgHpP1QmeYConavi Medical is focused on designing, manufacturing, and marketin

Newsfile 4 months ago

CNVIF
0.00%
JACC: Cardiovascular Interventions Publishes Peer-Reviewed Article on Emerging Hybrid Intracoronary Imaging Technologies

– Conavi Medical’s Novasight Hybrid™ System is the first technology to combine both IVUS and OCT to enable simultaneous and co-registered imaging of coronary arteries – – Company showcasing its Novasight technology this week at TCT 2024 – TORONTO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical”), a commercial stage company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is

GlobeNewswire 5 months ago

CNVIF
0.00%
Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services

TORONTO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- CONAVI MEDICAL CORP. (TSXV: CNVI) (“CONAVI MEDICAL” or the “Company”), a commercial stage company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce that it has engaged the services of ICP Securities Inc. (“ICP”) to provide automated market making services, including use of its proprietary algorithm, ICP Premium™, in compliance with the policies and

GlobeNewswire 6 months ago

CNVIF
0.00%

Performance Overview

Return	CNVI.V	S&P/TSX Composite index (^GSPTSE)
YTD	-40.00%	+1.03%
1-Year	-68.80%	+13.01%
3-Year	-68.80%	+19.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Conavi Medical Corp. (CNVI.V)

CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.

Conavi Medical to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

Conavi Medical Corp. Announces Closing of $20M Public Offering

Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares

Conavi Medical Announces Results From Its Annual General Meeting of Shareholders and Adoption of Amendments to Omnibus Equity Incentive Plan

Conavi Medical Corp. Announces Upsize to its Previously Announced Public Offering

Conavi Medical Announces Uplisting to OTCQB Venture Market

Conavi Medical Highly Encouraged by New U.S. Intracoronary Guidelines

Conavi Medical Reports Fiscal Q1 2025 Interim Financial Results and Operational Highlights

Conavi Medical Retains BND Projects Inc. for Corporate Development Services

Conavi Medical Corp. Announces Proposed Public Offering of Units

Conavi Medical Provides Shareholder Update and 2025 Outlook

Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review

Conavi Medical Announces Grant of Stock Options

Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights

Conavi Medical to Participate in the MedInvest MedTech, AI & Digital Health Conference

China's NMPA Approves EOM’s Coronary Imaging System Based on Conavi Medical’s IP

Conavi Medical Inc. (CNVI) Opens the Market

JACC: Cardiovascular Interventions Publishes Peer-Reviewed Article on Emerging Hybrid Intracoronary Imaging Technologies

Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services

Performance Overview